Biodistribution of Indium-111 labeled engineered human monoclonal antibody CTMO1 (hTMO1) in ovarian cancer patients: influence of prior administration of unlabeled hCTMO1

H. Prinssen; C.F.M. Molthoff; A.C. van Hof; RHM Verheijen; P. Kenemans; W. den Hollander; Q. Davies; A.J. Wilhelm; T. Baker; M. Sopwith; M. Frier; A. Perkins; E.M. Symonds; J.C. Roos

Biodistribution of Indium-111 labeled engineered human monoclonal antibody CTMO1 (hTMO1) in ovarian cancer patients: influence of prior administration of unlabeled hCTMO1

H. Prinssen, C.F.M. Molthoff, A.C. van Hof, RHM Verheijen, P. Kenemans, W. den Hollander, Q. Davies, A.J. Wilhelm, T. Baker, M. Sopwith, M. Frier, A. Perkins, E.M. Symonds, J.C. Roos

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 1996
Event	13th Hammersmith Conference - Kolymbari, Greece Duration: 17 Jun 1996 → …

Conference

Conference	13th Hammersmith Conference
Country/Territory	Greece
City	Kolymbari
Period	17/06/96 → …

Cite this

Prinssen, H., Molthoff, C. F. M., van Hof, A. C., Verheijen, RHM., Kenemans, P., den Hollander, W., Davies, Q., Wilhelm, A. J., Baker, T., Sopwith, M., Frier, M., Perkins, A., Symonds, E. M., & Roos, J. C. (1996). Biodistribution of Indium-111 labeled engineered human monoclonal antibody CTMO1 (hTMO1) in ovarian cancer patients: influence of prior administration of unlabeled hCTMO1. Abstract from 13th Hammersmith Conference, Kolymbari, Greece.

@conference{8c9b01264d434191a50c6ae4d0c3bfb9,

title = "Biodistribution of Indium-111 labeled engineered human monoclonal antibody CTMO1 (hTMO1) in ovarian cancer patients: influence of prior administration of unlabeled hCTMO1",

author = "H. Prinssen and C.F.M. Molthoff and {van Hof}, A.C. and RHM Verheijen and P. Kenemans and {den Hollander}, W. and Q. Davies and A.J. Wilhelm and T. Baker and M. Sopwith and M. Frier and A. Perkins and E.M. Symonds and J.C. Roos",

year = "1996",

language = "English",

note = "13th Hammersmith Conference ; Conference date: 17-06-1996",

}

Prinssen, H, Molthoff, CFM, van Hof, AC, Verheijen, RHM, Kenemans, P, den Hollander, W, Davies, Q, Wilhelm, AJ, Baker, T, Sopwith, M, Frier, M, Perkins, A, Symonds, EM & Roos, JC 1996, 'Biodistribution of Indium-111 labeled engineered human monoclonal antibody CTMO1 (hTMO1) in ovarian cancer patients: influence of prior administration of unlabeled hCTMO1', 13th Hammersmith Conference, Kolymbari, Greece, 17/06/96.

Biodistribution of Indium-111 labeled engineered human monoclonal antibody CTMO1 (hTMO1) in ovarian cancer patients: influence of prior administration of unlabeled hCTMO1. / Prinssen, H.; Molthoff, C.F.M.; van Hof, A.C. et al.
1996. Abstract from 13th Hammersmith Conference, Kolymbari, Greece.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Biodistribution of Indium-111 labeled engineered human monoclonal antibody CTMO1 (hTMO1) in ovarian cancer patients: influence of prior administration of unlabeled hCTMO1

AU - Prinssen, H.

AU - Molthoff, C.F.M.

AU - van Hof, A.C.

AU - Verheijen, RHM

AU - Kenemans, P.

AU - den Hollander, W.

AU - Davies, Q.

AU - Wilhelm, A.J.

AU - Baker, T.

AU - Sopwith, M.

AU - Frier, M.

AU - Perkins, A.

AU - Symonds, E.M.

AU - Roos, J.C.

PY - 1996

Y1 - 1996

M3 - Abstract

T2 - 13th Hammersmith Conference

Y2 - 17 June 1996

ER -